| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0057 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |